[The prognosis of the antianginal effect of foridon compared to other antianginal preparations].
The study covered 20 patients with angina pectoris. Antianginal drugs such as sydnopharm, kordafen, anaprilin, nitrosorbide, and foridon were tested by using pair exercise tests. All the patients had preliminary instrumental studies, including exercise test, echocardiography, hyperventilation and orthostatic tests, and variation pulsometry. A regression equation was derived, which could predict the efficacy of foridon from the findings of the tests used. The antianginal effect of foridon was found to be the weakest among the other drugs under study.
V V
VV
Shkarin
N A
NA
Naumova
V G
VG
Naumov
D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004452:Echocardiography; D005080:Exercise Test / Q000379:methods; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011379:Prognosis; D012129:Respiratory Function Tests / Q000379:methods
D002317:Cardiovascular Agents; D009543:Nifedipine; C045912:ryodipine